Deruaz, Cédric <br/><br/>
Levocetirizine better protects than desloratadine in a nasal provocation with allergen.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Apr 2004 
 - 669-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1016/j.jaci.2004.01.773  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Albumins--metabolism<br/>Allergens--immunology<br/>Biomarkers--analysis<br/>Cetirizine--therapeutic use<br/>Cross-Over Studies<br/>Differential Threshold<br/>Double-Blind Method<br/>Female<br/>Histamine H1 Antagonists, Non-Sedating--therapeutic use<br/>Humans<br/>Hypersensitivity--drug therapy<br/>Loratadine--analogs & derivatives<br/>Male<br/>Nasal Lavage Fluid--chemistry<br/>Nasal Provocation Tests<br/>Piperazines--therapeutic use<br/>Poaceae--immunology<br/>Pollen--immunology<br/>Treatment Outcome